Chemical respiratory sensitization-Current status of mechanistic understanding, knowledge gaps and possible identification methods of sensitizers.

adverse outcome pathway (AOP) chemical respiratory allergy chemical sensitizer chemical-induced hypersensitivity key event new approach methodology (NAM) occupational asthma respiratory sensitization

Journal

Frontiers in toxicology
ISSN: 2673-3080
Titre abrégé: Front Toxicol
Pays: Switzerland
ID NLM: 101777990

Informations de publication

Date de publication:
2024
Historique:
received: 01 11 2023
accepted: 27 05 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: epublish

Résumé

Respiratory sensitization is a complex immunological process eventually leading to hypersensitivity following re-exposure to the chemical. A frequent consequence is occupational asthma, which may occur after long latency periods. Although chemical-induced respiratory hypersensitivity has been known for decades, there are currently no comprehensive and validated approaches available for the prospective identification of chemicals that induce respiratory sensitization, while the expectations of new approach methodologies (NAMs) are high. A great hope is that due to a better understanding of the molecular key events, new methods can be developed now. However, this is a big challenge due to the different chemical classes to which respiratory sensitizers belong, as well as because of the complexity of the response and the late manifestation of symptoms. In this review article, the current information on respiratory sensitization related processes is summarized by introducing it in the available adverse outcome pathway (AOP) concept. Potentially useful models for prediction are discussed. Knowledge gaps and gaps of regulatory concern are identified.

Identifiants

pubmed: 39135743
doi: 10.3389/ftox.2024.1331803
pii: 1331803
pmc: PMC11317441
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1331803

Informations de copyright

Copyright © 2024 Hargitai, Parráková, Szatmári, Monfort-Lanzas, Galbiati, Audouze, Jornod, Staal, Burla, Chary, Gutleb, Lumniczky, Vandebriel and Gostner.

Déclaration de conflit d'intérêts

JG, RV, AG, and AC are National Experts contributing to the OECD Detailed Review Paper for respiratory sensitization. JG and RV were guest editors of Frontiers in Toxicology, at the time of submission. JG is co-inventor of EP3527653 and received funding from Egger GmbH, at the time the manuscript was composed. This had no impact on the content of the manuscript. AG and AC are co-inventors of WO 2018/122219 A1. AG is the founder of INVITROLIZE and SB is an employee of the same company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Rita Hargitai (R)

Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, National Centre for Public Health and Pharmacy (NCPHP), Budapest, Hungary.

Lucia Parráková (L)

Biochemical Immunotoxicology Group, Institute of Medical Biochemistry, Medical University of Innsbruck (MUI), Innsbruck, Austria.

Tünde Szatmári (T)

Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, National Centre for Public Health and Pharmacy (NCPHP), Budapest, Hungary.

Pablo Monfort-Lanzas (P)

Biochemical Immunotoxicology Group, Institute of Medical Biochemistry, Medical University of Innsbruck (MUI), Innsbruck, Austria.
Institute of Bioinformatics, Medical University of Innsbruck (MUI), Innsbruck, Austria.

Valentina Galbiati (V)

Laboratory of Toxicology, Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università Degli Studi di Milano (UNIMI), Milano, Italy.

Karine Audouze (K)

Inserm UMR-S 1124, Université Paris Cité, Paris, France.

Florence Jornod (F)

Inserm UMR-S 1124, Université Paris Cité, Paris, France.

Yvonne C M Staal (YCM)

Centre for Health Protection, National Institute of Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Sabina Burla (S)

Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg.

Aline Chary (A)

Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg.

Arno C Gutleb (AC)

Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg.

Katalin Lumniczky (K)

Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, National Centre for Public Health and Pharmacy (NCPHP), Budapest, Hungary.

Rob J Vandebriel (RJ)

Centre for Health Protection, National Institute of Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Johanna M Gostner (JM)

Biochemical Immunotoxicology Group, Institute of Medical Biochemistry, Medical University of Innsbruck (MUI), Innsbruck, Austria.

Classifications MeSH